Philippe Seguela - Publications

McGill University, Montreal, QC, Canada 

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Ase AR, Honson NS, Zaghdane H, Pfeifer TA, Séguéla P. Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels. Molecular Pharmacology. 87: 606-16. PMID 25597706 DOI: 10.1124/mol.114.096222  0.8
2013 Bernier LP, Ase AR, Séguéla P. Post-translational regulation of P2X receptor channels: modulation by phospholipids. Frontiers in Cellular Neuroscience. 7: 226. PMID 24324400 DOI: 10.3389/fncel.2013.00226  0.8
2013 Daou I, Tuttle AH, Longo G, Wieskopf JS, Bonin RP, Ase AR, Wood JN, De Koninck Y, Ribeiro-da-Silva A, Mogil JS, Séguéla P. Remote optogenetic activation and sensitization of pain pathways in freely moving mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18631-40. PMID 24259584 DOI: 10.1523/JNEUROSCI.2424-13.2013  0.8
2013 Bernier LP, Ase AR, Boué-Grabot É, Séguéla P. Inhibition of P2X4 function by P2Y6 UDP receptors in microglia. Glia. 61: 2038-49. PMID 24123515 DOI: 10.1002/glia.22574  0.8
2013 Zhang Z, Cordeiro Matos S, Jego S, Adamantidis A, Séguéla P. Norepinephrine drives persistent activity in prefrontal cortex via synergistic α1 and α2 adrenoceptors. Plos One. 8: e66122. PMID 23785477 DOI: 10.1371/journal.pone.0066122  0.8
2013 Wu C, Leong SY, Moore CS, Cui QL, Gris P, Bernier LP, Johnson TA, Séguéla P, Kennedy TE, Bar-Or A, Antel JP. Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation. Journal of Neuroinflammation. 10: 41. PMID 23509960 DOI: 10.1186/1742-2094-10-41  0.8
2013 Mo G, Peleshok JC, Cao CQ, Ribeiro-da-Silva A, Séguéla P. Control of P2X3 channel function by metabotropic P2Y2 utp receptors in primary sensory neurons. Molecular Pharmacology. 83: 640-7. PMID 23249537 DOI: 10.1124/mol.112.082099  0.8
2012 Bernier LP, Blais D, Boué-Grabot É, Séguéla P. A dual polybasic motif determines phosphoinositide binding and regulation in the P2X channel family. Plos One. 7: e40595. PMID 22792379 DOI: 10.1371/journal.pone.0040595  0.8
2012 Reinés A, Bernier LP, McAdam R, Belkaid W, Shan W, Koch AW, Séguéla P, Colman DR, Dhaunchak AS. N-cadherin prodomain processing regulates synaptogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 6323-34. PMID 22553038 DOI: 10.1523/JNEUROSCI.0916-12.2012  0.8
2012 Bernier LP, Ase AR, Boué-Grabot E, Séguéla P. P2X4 receptor channels form large noncytolytic pores in resting and activated microglia. Glia. 60: 728-37. PMID 22318986 DOI: 10.1002/glia.22301  0.8
2011 Mo G, Grant R, O'Donnell D, Ragsdale DS, Cao CQ, Séguéla P. Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase C. Molecular Pain. 7: 14. PMID 21314936 DOI: 10.1186/1744-8069-7-14  0.8
2011 Zimmerman B, Simaan M, Akoume MY, Houri N, Chevallier S, Séguéla P, Laporte SA. Role of ßarrestins in bradykinin B2 receptor-mediated signalling. Cellular Signalling. 23: 648-59. PMID 21145390 DOI: 10.1016/j.cellsig.2010.11.016  0.8
2011 Zhang Z, Reboreda A, Alonso A, Barker PA, Séguéla P. TRPC channels underlie cholinergic plateau potentials and persistent activity in entorhinal cortex. Hippocampus. 21: 386-97. PMID 20082292 DOI: 10.1002/hipo.20755  0.8
2010 Ase AR, Bernier LP, Blais D, Pankratov Y, Séguéla P. Modulation of heteromeric P2X1/5 receptors by phosphoinositides in astrocytes depends on the P2X1 subunit. Journal of Neurochemistry. 113: 1676-84. PMID 20374427 DOI: 10.1111/j.1471-4159.2010.06734.x  0.8
2009 Mo G, Bernier LP, Zhao Q, Chabot-Doré AJ, Ase AR, Logothetis D, Cao CQ, Séguéla P. Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors. Molecular Pain. 5: 47. PMID 19671169 DOI: 10.1186/1744-8069-5-47  0.8
2009 LaCroix-Fralish ML, Mo G, Smith SB, Sotocinal SG, Ritchie J, Austin JS, Melmed K, Schorscher-Petcu A, Laferriere AC, Lee TH, Romanovsky D, Liao G, Behlke MA, Clark DJ, Peltz G, et al. The beta3 subunit of the Na+,K+-ATPase mediates variable nociceptive sensitivity in the formalin test. Pain. 144: 294-302. PMID 19464798 DOI: 10.1016/j.pain.2009.04.028  0.8
2009 Curia G, Papouin T, Séguéla P, Avoli M. Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cerebral Cortex (New York, N.Y. : 1991). 19: 1515-20. PMID 18787232 DOI: 10.1093/cercor/bhn159  0.8
2008 Bernier LP, Ase AR, Chevallier S, Blais D, Zhao Q, Boué-Grabot E, Logothetis D, Séguéla P. Phosphoinositides regulate P2X4 ATP-gated channels through direct interactions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12938-45. PMID 19036987 DOI: 10.1523/JNEUROSCI.3038-08.2008  0.8
2008 Bernier LP, Ase AR, Tong X, Hamel E, Blais D, Zhao Q, Logothetis DE, Séguéla P. Direct modulation of P2X1 receptor-channels by the lipid phosphatidylinositol 4,5-bisphosphate. Molecular Pharmacology. 74: 785-92. PMID 18523136 DOI: 10.1124/mol.108.047019  0.8
2007 Joch M, Ase AR, Chen CX, MacDonald PA, Kontogiannea M, Corera AT, Brice A, Séguéla P, Fon EA. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels. Molecular Biology of the Cell. 18: 3105-18. PMID 17553932 DOI: 10.1091/mbc.E05-11-1027  0.8
2007 Toulmé E, Blais D, Léger C, Landry M, Garret M, Séguéla P, Boué-Grabot E. An intracellular motif of P2X(3) receptors is required for functional cross-talk with GABA(A) receptors in nociceptive DRG neurons. Journal of Neurochemistry. 102: 1357-68. PMID 17498217 DOI: 10.1111/j.1471-4159.2007.04640.x  0.8
2007 Zhao Q, Logothetis DE, Séguéla P. Regulation of ATP-gated P2X receptors by phosphoinositides. PflüGers Archiv : European Journal of Physiology. 455: 181-5. PMID 17479282 DOI: 10.1007/s00424-007-0271-x  0.8
2007 Reboreda A, Raouf R, Alonso A, Séguéla P. Development of cholinergic modulation and graded persistent activity in layer v of medial entorhinal cortex. Journal of Neurophysiology. 97: 3937-47. PMID 17442765 DOI: 10.1152/jn.01233.2006  0.8
2006 Sharif Naeini R, Witty MF, Séguéla P, Bourque CW. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nature Neuroscience. 9: 93-8. PMID 16327782 DOI: 10.1038/nn1614  0.8
2005 Mogil JS, Breese NM, Witty MF, Ritchie J, Rainville ML, Ase A, Abbadi N, Stucky CL, Séguéla P. Transgenic expression of a dominant-negative ASIC3 subunit leads to increased sensitivity to mechanical and inflammatory stimuli. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9893-901. PMID 16251436 DOI: 10.1523/JNEUROSCI.2019-05.2005  0.8
2004 Raouf R, Chakfe Y, Blais D, Speelman A, Boué-Grabot E, Henderson D, Séguéla P. Selective knock-down of P2X7 ATP receptor function by dominant-negative subunits. Molecular Pharmacology. 65: 646-54. PMID 14978243 DOI: 10.1124/mol.65.3.646  0.8
2003 Boué-Grabot E, Barajas-López C, Chakfe Y, Blais D, Bélanger D, Emerit MB, Séguéla P. Intracellular cross talk and physical interaction between two classes of neurotransmitter-gated channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1246-53. PMID 12598613  0.8
2002 Chakfe Y, Seguin R, Antel JP, Morissette C, Malo D, Henderson D, Séguéla P. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3061-9. PMID 11943809  0.8
2001 Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Séguéla P, Voigt M, Humphrey PP. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacological Reviews. 53: 107-18. PMID 11171941  0.8
2001 Biagini G, Babinski K, Avoli M, Marcinkiewicz M, Séguéla P. Regional and subunit-specific downregulation of acid-sensing ion channels in the pilocarpine model of epilepsy. Neurobiology of Disease. 8: 45-58. PMID 11162239 DOI: 10.1006/nbdi.2000.0331  0.8
1998 Lê KT, Villeneuve P, Ramjaun AR, McPherson PS, Beaudet A, Séguéla P. Sensory presynaptic and widespread somatodendritic immunolocalization of central ionotropic P2X ATP receptors. Neuroscience. 83: 177-90. PMID 9466408 DOI: 10.1016/S0306-4522(97)00365-5  0.8
1997 Lê KT, Paquet M, Nouel D, Babinski K, Séguéla P. Primary structure and expression of a naturally truncated human P2X ATP receptor subunit from brain and immune system. Febs Letters. 418: 195-9. PMID 9414125 DOI: 10.1016/S0014-5793(97)01380-X  0.8
1997 Botto JM, Chabry J, Nouel D, Paquet M, Séguéla P, Vincent JP, Beaudet A, Mazella J. Identification in the rat neurotensin receptor of amino-acid residues critical for the binding of neurotensin. Brain Research. Molecular Brain Research. 46: 311-7. PMID 9191107 DOI: 10.1016/S0169-328X(97)00006-5  0.8
1996 Séguéla P, Haghighi A, Soghomonian JJ, Cooper E. A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 448-55. PMID 8551329  0.8
1993 Séguéla P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 596-604. PMID 7678857  0.8
1991 Oleskevich S, Descarries L, Watkins KC, Séguéla P, Daszuta A. Ultrastructural features of the serotonin innervation in adult rat hippocampus: an immunocytochemical description in single and serial thin sections. Neuroscience. 42: 777-91. PMID 1956515 DOI: 10.1016/0306-4522(91)90044-O  0.8
1990 Descarries L, Audet MA, Doucet G, Garcia S, Oleskevich S, Séguéla P, Soghomonian JJ, Watkins KC. Morphology of central serotonin neurons. Brief review of quantified aspects of their distribution and ultrastructural relationships. Annals of the New York Academy of Sciences. 600: 81-92. PMID 2252339 DOI: 10.1111/j.1749-6632.1990.tb16874.x  0.8
1990 Luetje CW, Patrick J, Séguéla P. Nicotine receptors in the mammalian brain. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 4: 2753-60. PMID 2197155  0.8
1990 Séguéla P, Watkins KC, Geffard M, Descarries L. Noradrenaline axon terminals in adult rat neocortex: an immunocytochemical analysis in serial thin sections. Neuroscience. 35: 249-64. PMID 2116602 DOI: 10.1016/0306-4522(90)90079-J  0.8
1989 Séguéla P, Watkins KC, Descarries L. Ultrastructural relationships of serotonin axon terminals in the cerebral cortex of the adult rat. The Journal of Comparative Neurology. 289: 129-42. PMID 2808757 DOI: 10.1002/cne.902890111  0.8
1988 Séguéla P, Watkins KC, Descarries L. Ultrastructural features of dopamine axon terminals in the anteromedial and the suprarhinal cortex of adult rat. Brain Research. 442: 11-22. PMID 3359247 DOI: 10.1016/0006-8993(88)91427-8  0.8
1988 Arsenault MY, Parent A, Séguéla P, Descarries L. Distribution and morphological characteristics of dopamine-immunoreactive neurons in the midbrain of the squirrel monkey (Saimiri sciureus). The Journal of Comparative Neurology. 267: 489-506. PMID 3346372 DOI: 10.1002/cne.902670404  0.8
1987 Smith Y, Parent A, Seguela P, Descarries L. Distribution of GABA-immunoreactive neurons in the basal ganglia of the squirrel monkey (Saimiri sciureus). The Journal of Comparative Neurology. 259: 50-64. PMID 3294929 DOI: 10.1002/cne.902590105  0.8
1986 Gamrani H, Onteniente B, Seguela P, Geffard M, Calas A. Gamma-aminobutyric acid-immunoreactivity in the rat hippocampus. A light and electron microscopic study with anti-GABA antibodies. Brain Research. 364: 30-8. PMID 3512033 DOI: 10.1016/0006-8993(86)90984-4  0.8
1986 Lescaudron L, Seguela P, Geffard M, Verna A. Effects of long-term ethanol consumption on GABAergic neurons in the mouse hippocampus: a quantitative immunocytochemical study. Drug and Alcohol Dependence. 18: 377-84. PMID 3028747 DOI: 10.1016/0376-8716(86)90102-X  0.8
1985 Geffard M, Henrich-Rock AM, Dulluc J, Seguela P. Antisera against small neurotransmitter-like molecules. Neurochemistry International. 7: 403-13. PMID 20492941 DOI: 10.1016/0197-0186(85)90162-7  0.8
1985 Seguela P, Gamrani H, Geffard M, Calas A, Le Moal M. Ultrastructural immunocytochemistry of gamma-aminobutyrate in the cerebral and cerebellar cortex of the rat. Neuroscience. 16: 865-74. PMID 3912678 DOI: 10.1016/0306-4522(85)90101-0  0.8
1984 Geffard M, Buijs RM, Seguela P, Pool CW, Le Moal M. First demonstration of highly specific and sensitive antibodies against dopamine. Brain Research. 294: 161-5. PMID 6697233 DOI: 10.1016/0006-8993(84)91323-4  0.8
1984 Seguela P, Geffard M, Buijs RM, Le Moal M. Antibodies against gamma-aminobutyric acid: specificity studies and immunocytochemical results. Proceedings of the National Academy of Sciences of the United States of America. 81: 3888-92. PMID 6587397  0.8
1984 Geffard M, Seguela P, Heinrich-Rock AM. Antisera against catecholamines: specificity studies and physicochemical data for anti-dopamine and anti-p-tyramine antibodies. Molecular Immunology. 21: 515-22. PMID 6431267 DOI: 10.1016/0161-5890(84)90067-1  0.8
1984 Geffard M, Kah O, Onteniente B, Seguela P, Le Moal M, Delaage M. Antibodies to dopamine: radioimmunological study of specificity in relation to immunocytochemistry. Journal of Neurochemistry. 42: 1593-9. PMID 6427408  0.8
1984 Geffard M, Seguela P, Buijs RM. Immunorecognition of anti-serotonin antibodies by using a radiolabelled ligand. Neuroscience Letters. 50: 217-22. PMID 6387546 DOI: 10.1016/0304-3940(84)90489-0  0.8
Show low-probability matches.